Neonatal Hearing Loss: Genetic and Environmental Causes
Hearing supports early communication, bonding, feeding-related interaction, and the development of language. When a newborn has reduced access to sound, timely recognition can make a major difference to family support, diagnostic planning, and intervention. Neonatal hearing loss may be present at birth or emerge during infancy, so a normal first screen does not always eliminate later risk.
The causes are diverse. A change in a gene may affect the inner ear, auditory nerve, or broader developmental pathways. In other infants, hearing impairment is associated with congenital infection, prematurity, hypoxia, ototoxic medication, structural abnormalities, or harmful prenatal exposures. Some cases involve several contributing factors rather than one isolated cause.
Perinatal teams therefore need an approach that combines universal screening with careful review of family history, pregnancy, delivery, neonatal treatment, and postnatal development. Understanding the distinction between inherited and acquired auditory disorders helps clinicians choose appropriate follow-up without creating unnecessary anxiety for parents.
Why Early Hearing Detection Matters
The cochlea converts sound vibrations into nerve signals, while the auditory nerve carries those signals to the brain. Disruption at any point can produce conductive, sensorineural, or mixed hearing loss. Conductive problems affect sound transmission through the outer or middle ear; sensorineural loss involves the cochlea or auditory pathway; mixed loss includes both mechanisms.
Early hearing impairment can influence speech perception and language acquisition, particularly when it is bilateral, severe, or profound. The effect is not determined by hearing thresholds alone. Access to communication, the age at which support begins, cognitive development, family involvement, and the presence of other conditions all shape outcomes.
Universal newborn hearing screening commonly uses otoacoustic emissions or automated auditory brainstem response testing. These tools are screening methods rather than complete diagnostic evaluations. Fluid in the middle ear, movement, noise, or technical factors can produce a “refer” result, while some forms of auditory neuropathy may require specific testing to identify.
A screening result should therefore lead to a clear pathway. Infants who do not pass should receive timely rescreening or diagnostic audiology, and those with recognized risk factors need surveillance even when the initial screen is satisfactory.
Genetic Pathways Behind Hearing Loss
Inherited hearing loss may be nonsyndromic, affecting hearing without obvious abnormalities elsewhere, or syndromic, occurring with changes in the eyes, kidneys, heart, pigment, skeletal system, or nervous system. Genetic variants can interfere with hair-cell development, ion transport, cell adhesion, or the maintenance of cochlear structures.
Variants in GJB2 are among the most frequently identified genetic contributors to nonsyndromic sensorineural hearing loss in many populations. Other genes, including SLC26A4, OTOF, MYO7A, and mitochondrial genes, may be relevant depending on the clinical pattern and the family’s ancestry. A lack of affected relatives does not exclude an inherited cause because recessive conditions can appear unexpectedly, and new variants can arise without a previous family history.
Mitochondrial disorders deserve particular attention because they may involve progressive hearing loss and can be transmitted through the maternal line. Some genetic conditions produce delayed-onset or fluctuating impairment, so children who pass neonatal screening may still need later assessment if speech development, auditory responses, or developmental progress raise concern.
Genetic evaluation is most useful when guided by an audiologic phenotype and a physical examination. Counseling should explain what testing can and cannot reveal, including uncertain findings, variable expression, implications for relatives, and possible relevance to future pregnancies. Genetic results should complement, rather than replace, ongoing hearing and developmental monitoring.
Environmental and Acquired Contributors
Prenatal and perinatal exposures can injure the auditory system directly or increase vulnerability during a critical stage of development. Congenital cytomegalovirus is a particularly important cause because hearing loss may be unilateral, progressive, or delayed. Other congenital infections, including toxoplasmosis, rubella, herpes viruses, and syphilis, may affect hearing as part of a wider pattern of fetal or neonatal disease.
Alcohol exposure during pregnancy can affect the developing brain and sensory systems. Information on fetal alcohol disorders is relevant to perinatal services because prevention, early recognition, and coordinated developmental care may identify children who need hearing assessment alongside broader support. Hearing concerns in these children should be evaluated on their own clinical merits rather than assumed to result from a single exposure.
Neonatal intensive care introduces other potential risks. Very low birth weight, prolonged mechanical ventilation, severe jaundice, hypoxic-ischaemic injury, meningitis, and sepsis can be associated with auditory damage. Aminoglycoside antibiotics and loop diuretics may be ototoxic, especially when treatment is prolonged, doses are high, renal function is impaired, or several risk factors occur together.
Noise exposure is another modifiable concern. Intensive care equipment, alarms, procedures, and poor sound management can add stress to an immature auditory system, although the relationship between routine neonatal noise and permanent hearing loss is complex. Units should follow medication monitoring policies, reduce avoidable noise, document risk exposures, and arrange surveillance for infants receiving prolonged intensive care.
Screening, Diagnosis, and Monitoring
The screening method should reflect the infant’s medical history. Otoacoustic emissions measure sound generated by functioning outer hair cells, whereas automated auditory brainstem response evaluates neural responses to sound. Infants who have spent substantial time in intensive care are often screened with auditory brainstem response because auditory neuropathy can be missed by emissions testing alone.
A failed screen does not establish permanent deafness. It may reflect vernix, middle-ear fluid, transient inflammation, poor probe placement, or movement. However, repeated referrals should never be dismissed as technical inconvenience. Diagnostic assessment may include tympanometry, behavioral audiometry when developmentally appropriate, diagnostic auditory brainstem response, bone-conduction testing, and examination by an ear, nose, and throat specialist.
| Clinical situation | Possible mechanism | Useful next step |
|---|---|---|
| Failed initial screen in a well newborn | Temporary debris or middle-ear fluid; possible sensorineural loss | Complete repeat screening promptly, followed by diagnostic testing if the infant does not pass |
| Neonatal intensive care admission | Hypoxia, infection, ototoxic exposure, or auditory neuropathy | Use risk-based surveillance and consider diagnostic brainstem response |
| Family history of childhood deafness | Recessive, dominant, X-linked, or mitochondrial inheritance | Detailed pedigree, audiology, and genetics referral when indicated |
| Congenital cytomegalovirus or another infection | Cochlear injury or delayed neural damage | Early targeted evaluation with continued developmental and audiologic follow-up |
| Normal screen but later speech or response concerns | Delayed-onset, progressive, or mild hearing impairment | Prompt diagnostic audiology rather than waiting for routine milestones |
Monitoring should continue after the newborn period when risk factors are present. Parents and primary-care clinicians can observe responses to voices, sound localization, vocal development, and changes in communication. Concerns should trigger assessment even if the child previously passed screening. A child with unilateral loss, mild impairment, or fluctuating conductive disease may appear to hear well in quiet settings while struggling in daily communication.
Making Sense of Risk and Family History
A family history should cover hearing loss in parents, siblings, grandparents, cousins, and previous pregnancies. The age at onset, severity, side affected, progression, associated medical features, and known genetic diagnoses are all important. Consanguinity and ancestry may alter the likelihood of particular recessive conditions, but they should be discussed sensitively and without assuming causation.
Clinical teams should distinguish risk markers from diagnoses. Prematurity increases the need for surveillance, but it does not mean hearing loss is inevitable. Exposure to an ototoxic medicine may justify follow-up, yet the medication may have been essential and appropriately administered. Similarly, a genetic variant may explain susceptibility without predicting the exact age, severity, or progression of impairment.
When sensorineural loss is confirmed, evaluation may include imaging of the temporal bones and internal auditory canals, ophthalmologic examination, electrocardiography, laboratory studies for selected infections, and genetic testing. The work-up should be individualized. Excessive testing can burden families and produce ambiguous findings, while inadequate investigation may miss a treatable condition or a wider syndrome.
Communication with parents is part of clinical care. Families need a plain-language explanation of the result, the difference between screening and diagnosis, the expected timeline, and available communication options. Early intervention can include hearing technology, speech and language services, sign language, family-centered educational support, and specialist care according to the child’s needs and family preferences.
Coordinated Care Across the Perinatal Pathway
Neonatal hearing assessment works best when maternity, neonatal, audiology, genetics, infectious disease, otolaryngology, and primary-care services share information. A discharge summary should record screening results, risk factors, medications with potential ototoxicity, congenital infection findings, and the responsible service for follow-up.
Reliable tracking systems are especially important for infants who move between hospitals or regions. Missed appointments can occur when families are coping with feeding difficulties, transport barriers, housing instability, or other medical demands. Reminder systems, interpreter access, community health workers, and direct referral pathways can reduce loss to follow-up.
Research and education remain central to improving perinatal hearing care. The FAOPS 2020 congress site reflects the wider scientific setting in which specialists in Asian and Oceanian perinatal medicine shared work on neonatal health, developmental outcomes, and clinical research. Although the Tokyo meeting was canceled during the COVID-19 pandemic, its subject area remains highly relevant to modern newborn services.
Practical Priorities for Clinical Teams
- Complete newborn hearing screening before discharge whenever possible and document the result clearly.
- Use risk-based surveillance for intensive care, congenital infection, family history, craniofacial differences, and ototoxic exposure.
- Refer promptly for diagnostic audiology after a repeated failed screen or any parental or developmental concern.
- Offer genetics and infectious-disease evaluation when the clinical pattern suggests an inherited or congenital cause.
- Provide families with accessible information, coordinated follow-up, and communication-support options after confirmed hearing loss.
The most effective response to neonatal hearing impairment is a continuous pathway rather than a single test. Screening identifies infants who need attention, diagnostic assessment defines the type and severity of loss, and follow-up reveals whether hearing remains stable or changes over time. Genetic and environmental information adds context that can guide medical care and family counseling.
Perinatal services can strengthen outcomes by treating every failed screen as a prompt for reliable follow-up, every risk factor as a reason for proportionate surveillance, and every confirmed diagnosis as an opportunity for early family-centered support. Use these principles to review local newborn hearing pathways, improve documentation, and connect infants with audiology and developmental services without delay.
